2022
DOI: 10.1007/s11259-022-09971-y
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of effects of a single dose of MHYOSPHERE® PCV ID with three commercial porcine vaccine associations against Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) on piglet growth during the nursery period under field conditions

Abstract: Pigs routinely undergo stressful vaccination procedures, which are often unavoidable given the unavailability of safer alternatives, challenging animal welfare. The available vaccines for Mycoplasma hyopneumoniae (Mhyo) or Porcine circovirus type 2 (PCV2) are mostly administered intramuscularly in association to prevent Porcine respiratory disease complex (PRDC). MHYOSPHERE® PCV ID is the first vaccine protecting from both agents by intradermal route. This randomized, blind-field trial aimed to compare the eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 21 publications
(30 reference statements)
1
3
0
Order By: Relevance
“…As could be observed in our study and based on observations in other farms, piglets vaccinated intramuscularly with vaccine A stopped feeding for about one day and exhibited depressed behavior. This was reflected in higher weights in animals of group B at time point 2, i.e., at week 15, and was also already observed in another study comparing these two vaccines [ 19 ]. However, this difference was reversed at the time of slaughter, albeit not at a significant level.…”
Section: Discussionsupporting
confidence: 77%
“…As could be observed in our study and based on observations in other farms, piglets vaccinated intramuscularly with vaccine A stopped feeding for about one day and exhibited depressed behavior. This was reflected in higher weights in animals of group B at time point 2, i.e., at week 15, and was also already observed in another study comparing these two vaccines [ 19 ]. However, this difference was reversed at the time of slaughter, albeit not at a significant level.…”
Section: Discussionsupporting
confidence: 77%
“…Adjuvants are used to enhance and modulate vaccine-induced immunity. Over 60% of identified papers using skin-based vaccination in pigs included adjuvants; the majority mixed or co-inoculated with the vaccine [ 51 , 76 , 88 , 108 , 110 , 112 , 113 , 115 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 129 , 131 , 132 , 133 , 134 , 137 , 138 , 139 , 140 , 141 , 142 , 143 , 144 , 146 , 151 , 153 , 154 , 156 , 158 , 159 , 160 , 161 , 168 , 179 , 180 , 182 , 186 , 187 , 188 , 196 , 198 , 199 , 201 , 202 ,…”
Section: Resultsmentioning
confidence: 99%
“…Out of the 117 papers, 10 focus on safety aspects with no mention of the immune response [ 108 , 130 , 149 , 154 , 160 , 168 , 185 , 200 , 201 , 216 ] and 3 focus on the innate immune response [ 88 , 199 , 207 ]. The remaining 104 papers assess vaccine-induced adaptive immunity and/or efficacy.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation